Summary
Pfizer Inc. (PFE) filed an 8-K on January 22, 2004, to report its financial results for the fourth quarter and full year ended December 31, 2003. This filing primarily serves to provide public access to the press release detailing these key financial performance metrics. Investors should review the furnished press release (Exhibit 99) for comprehensive details on revenue, earnings, and other operational and financial conditions for the reported periods. This report highlights Pfizer's financial performance as it concluded the 2003 fiscal year. The press release, incorporated by reference, is the primary source of information for understanding the company's financial health and operational achievements during the fourth quarter and the entirety of 2003. Investors seeking to evaluate Pfizer's recent performance and future prospects should refer to the detailed financial data presented in this exhibit.
Key Highlights
- 1Pfizer Inc. reported its financial results for the fourth quarter and full year ended December 31, 2003.
- 2The results were announced via a press release issued on January 22, 2004.
- 3The press release is filed as Exhibit 99 to this Form 8-K.
- 4This filing makes the detailed financial results publicly available.
- 5Investors can access the press release for specific financial figures and performance metrics.